Epsolay (Benzoyl Peroxide) Patent Expiration, LOE Window & CMS Spending

Epsolay (Benzoyl Peroxide) by Mayne: FDA Orange Book LOE 2041-05-23, 0 AB generics, $489K 2024 CMS Part D & Medicaid spend, and 2 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorMayne
FDA Application & PathwayN214510 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2041-05-23
Orange Book Patents (*PED Extensions)14 patents (0 *PED)
Active AB-Rated Generic Competitors0
2024 CMS Total Public Spend$489K
2024 Medicare Part D Spend$463K
2024 Medicaid Spend$26K
Reported Wholesale Price Change (CA SB 17)2 WAC filings (max 60.9% 2-yr change)